Clearstead Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Clearstead Advisors’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$6.11K	Hold
2024 Q4	$9.31K	Hold
2024 Q3	$9.3K	Hold
2024 Q2	$8.15K	Buy